People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Virion Therapeutics, LLC | — | Biotechnology | Series A | $10.9M | $205.0M | 2017 |
| Golo, LLC | — | Other Health Care | Seed | $4.7M | $60.7M | 2015 |
Bernard Rudnick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bernard Rudnick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chris Lundin | 1 | 1 |
| Peter Christof Ungermann | 1 | 1 |
| Tony Smith Hastie | 1 | 1 |
| Jennifer Brooks | 1 | 1 |
| Andrew Luber | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.